Loading...
Carvedilol
India Pharmaceutical Trade Intelligence
Who Supplies Carvedilol to India from CHINA
India's carvedilol imports from CHINA total $11.8K across 18 shipments from 5 foreign suppliers. ZHEJIANG HUAHAI PHARMACEUTICAL leads with $5.6K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include HETERO LABS LIMITED. This corridor reflects India's pharmaceutical import demand for carvedilol — a diversified sourcing base with multiple active suppliers from CHINA.
Top foreign suppliers (CHINA) — Ranked by import value
ZHEJIANG HUAHAI PHARMACEUTICAL is the leading Carvedilol supplier from CHINA to India, with import value of $5.6K across 2 shipments. The top 5 suppliers — ZHEJIANG HUAHAI PHARMACEUTICAL, ZHEJIANG HUAHAI PHARMACEUTICAL CO. LTD, YICHANG HUMANWELL PHARMACEUTICAL CO , LTD, YICHANG HUMANWELL PHARMACEUTICAL CO LTD, YICHANG HUMANWELL PHARMACEUTICALS CO., LTD — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (CHINA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ZHEJIANG HUAHAI PHARMACEUTICAL | $5.6K | 2 | 47.7% |
| 2 | ZHEJIANG HUAHAI PHARMACEUTICAL CO. LTD | $3.8K | 1 | 32.0% |
| 3 | YICHANG HUMANWELL PHARMACEUTICAL CO , LTD | $2.0K | 11 | 17.0% |
| 4 | YICHANG HUMANWELL PHARMACEUTICAL CO LTD | $294 | 2 | 2.5% |
| 5 | YICHANG HUMANWELL PHARMACEUTICALS CO., LTD | $85 | 2 | 0.7% |
Showing top 5 of 5 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from CHINA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | HETERO LABS LIMITED | $5.6K | 2 | 47.7% |
| 2 | WATSON PHARMA PRIVATE LIMITED | $3.8K | 1 | 32.0% |
| 3 | VIMTA LABS LIMITED | $2.4K | 15 | 20.2% |
Import Statistics
- Import Value
- $11.8K
- Shipments
- 18
- Foreign Suppliers
- 5
- Indian Buyers
- 3
- Avg. Shipment
- $655
Other Carvedilol Import Origins
Related Analysis
Frequently Asked Questions — Carvedilol Imports from CHINA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Carvedilol suppliers from CHINA to India?
The top Carvedilol suppliers from CHINA to India include ZHEJIANG HUAHAI PHARMACEUTICAL, ZHEJIANG HUAHAI PHARMACEUTICAL CO. LTD, YICHANG HUMANWELL PHARMACEUTICAL CO , LTD. The leading supplier is ZHEJIANG HUAHAI PHARMACEUTICAL with import value of $5.6K USD across 2 shipments. India imported Carvedilol worth $11.8K USD from CHINA in total across 18 shipments.
QHow much Carvedilol does India import from CHINA?
India imported Carvedilol worth $11.8K USD from CHINA across 18 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Carvedilol from CHINA?
The main Indian buyers of Carvedilol sourced from CHINA include HETERO LABS LIMITED, WATSON PHARMA PRIVATE LIMITED, VIMTA LABS LIMITED. The largest buyer is HETERO LABS LIMITED with $5.6K in imports across 2 shipments.
QWhat is the total value of Carvedilol imports from CHINA to India?
The total value of Carvedilol imports from CHINA to India is $11.8K USD, across 18 shipments and 5 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: CHINA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Carvedilol.
- 2.Supplier/Buyer Matching: 5 foreign suppliers from CHINA and 3 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $11.8K aggregated from 18 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
18 Verified Shipments
5 suppliers, 3 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists